Lerut J, Tzakis A G, Bron K, Gordon R D, Iwatsuki S, Esquivel C O, Makowka L, Todo S, Starzl T E
Ann Surg. 1987 Apr;205(4):404-14. doi: 10.1097/00000658-198704000-00011.
In 313 consecutive recipients of 393 orthotopic liver grafts, there were 51 (16.3%) and nine (2.9%) patients who had pre-existing portal vein and inferior vena cava abnormalities, respectively. These abnormalities required adjustments in the transplant operation and were a source of morbidity and mortality. The incidence of thrombosis of the reconstructed portal vein was 1.8%. Only three (0.8%) vena caval thromboses were seen after 393 liver replacements. Venous stenoses or disruptions were rare. Six women with the Budd-Chiari syndrome had liver replacement. Although this disorder is a veno-occlusive disease, five of the recipients achieved prolonged survival, only one had recurrence of disease, and three are alive after 2-6 years.
在313例接受393例原位肝移植的连续患者中，分别有51例（16.3%）和9例（2.9%）患者术前存在门静脉和下腔静脉异常。这些异常需要对移植手术进行调整，并且是发病和死亡的一个原因。重建门静脉血栓形成的发生率为1.8%。在393例肝移植术后仅发现3例（0.8%）腔静脉血栓形成。静脉狭窄或中断很少见。6例患有布加综合征的女性接受了肝移植。尽管这种疾病是一种静脉闭塞性疾病，但5例受者获得了长期生存，仅1例疾病复发，3例在2至6年后仍存活。
